healthcare News
Lexicon shares fall 20% after $94.6M discounted equity offering
Biotech prices shares at $1.30, 9.7% below market, adding roughly 39 million new shares to existing float
Moderna surges on Recordati deal for rare disease therapy
Strategic partnership expands mRNA technology beyond COVID vaccines into metabolic disorders
Regenxbio director shows confidence amid FDA clinical hold
Insider exercise of 225,000 options follows 35% premarket plunge after tumor detection in gene therapy trial
Pro-Dex surges on earnings beat, 3-year contract renewal
Medical device maker beats EPS and revenue estimates while securing extended agreement with largest customer
Thermo Fisher beats estimates on strong Q4, OpenAI AI deal
Scientific instruments maker returned $3.6bn to shareholders in 2025 through buybacks and dividends
Danaher slides 4.8% on weak Life Sciences outlook despite Q4 earnings beat
Healthcare conglomerate tops estimates but flat 2026 projection for core life sciences segment spooks investors
Nurix beats estimates as bexobrutideg advances in pivotal trials
83% response rate in CLL patients drives analyst optimism; $593M cash runway supports Phase 3 program
Altimmune shares plunge 16% on $75M stock offering pricing
Clinical-stage biotech prices direct offering at 29% discount to fund Phase 3 MASH trial